The US FDA Has Approved Takhzyro for the Treatment of Hereditary Angioedema
The US Food and Drug Administration has approved a drug called TakhzyroTM (lanadelumab-flyo) for the treatment of hereditary angioedema. This approval was based on supporting evidence from several studies, including from…